Plasma markers of COVID-19 severity: a pilot study

BACKGROUND: SARS-CoV-2 infected patients show heterogeneous clinical presentations ranging from mild symptoms to severe respiratory failure and death. Consequently, various markers reflect this wide spectrum of disease presentations. METHODS: Our pilot cohort included moderate (n = 10) and severe (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Beimdiek, Julia, Janciauskiene, Sabina, Wrenger, Sabine, Volland, Sonja, Rozy, Adriana, Fuge, Jan, Olejnicka, Beata, Pink, Isabell, Illig, Thomas, Popov, Alexander, Chorostowska, Joanna, Buettner, Falk F. R., Welte, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745704/
https://www.ncbi.nlm.nih.gov/pubmed/36514048
http://dx.doi.org/10.1186/s12931-022-02272-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745704/
https://www.ncbi.nlm.nih.gov/pubmed/36514048
http://dx.doi.org/10.1186/s12931-022-02272-7

Ejemplares similares